Related Experiment Video

Updated: Oct 2, 2025

Automated Radiochemical Synthesis of [18F]3F4AP: A Novel PET Tracer for Imaging Demyelinating Diseases
11:03

Automated Radiochemical Synthesis of [18F]3F4AP: A Novel PET Tracer for Imaging Demyelinating Diseases

Published on: May 29, 2017

10.1K

Correction to Novel Thienopyrimidine-Based PET Tracers for P2Y12 Receptor Imaging in the Brain

Berend van der Wildt, Bieneke Janssen, Aleksandra Pekošak

    ACS Chemical Neuroscience
    |February 22, 2022
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Solid Phase 11C-Methylation, Purification and Formulation for the Production of PET Tracers
    09:25

    Solid Phase 11C-Methylation, Purification and Formulation for the Production of PET Tracers

    Published on: October 24, 2019

    6.8K
    PET Imaging of Neuroinflammation Using [11C]DPA-713 in a Mouse Model of Ischemic Stroke
    12:01

    PET Imaging of Neuroinflammation Using [11C]DPA-713 in a Mouse Model of Ischemic Stroke

    Published on: June 14, 2018

    12.9K

    Related Experiment Videos

    Last Updated: Oct 2, 2025

    Automated Radiochemical Synthesis of [18F]3F4AP: A Novel PET Tracer for Imaging Demyelinating Diseases
    11:03

    Automated Radiochemical Synthesis of [18F]3F4AP: A Novel PET Tracer for Imaging Demyelinating Diseases

    Published on: May 29, 2017

    10.1K
    Solid Phase 11C-Methylation, Purification and Formulation for the Production of PET Tracers
    09:25

    Solid Phase 11C-Methylation, Purification and Formulation for the Production of PET Tracers

    Published on: October 24, 2019

    6.8K
    PET Imaging of Neuroinflammation Using [11C]DPA-713 in a Mouse Model of Ischemic Stroke
    12:01

    PET Imaging of Neuroinflammation Using [11C]DPA-713 in a Mouse Model of Ischemic Stroke

    Published on: June 14, 2018

    12.9K

    Related Concept Videos

    Positron Emission Tomography01:29

    Positron Emission Tomography

    6.0K
    Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
    One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
    6.0K
    Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

    Imaging Studies II: Positron Emission Tomography and Scintigraphy

    253
    Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
    Fundamental Principles of PET
    253

    Articles linked to this work by shared authors, journal, and citation graph.

    Decreased functional connectivity in post-COVID syndrome patients with high neuroinflammatory activity.

    NeuroImage·2026

    Na[18F]F PET/CT quantification in spondyloarthritis: comparative evaluation of SUV normalization approaches.

    EJNMMI research·2025

    Direct decarboxylative 18F-fluorination of benzoic acids using visible light catalysis.

    Chemical communications (Cambridge, England)·2025

    New lens on congenital mild bone fragility: a novel Col1a1 knockout mouse model for osteogenesis imperfecta type 1.

    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·2025

    Varying Levels of Inflammatory Activity in Brain and Body of Patients with Persistent Fatigue and Difficulty Concentrating After COVID-19: A TSPO PET Study.

    Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2025

    Exploration of Fluorinated Pyrazolidine-3,5-Diones for Positron Emission Tomography Imaging of the P2Y12 Receptor in the Central Nervous System.

    ChemMedChem·2025

    Body Temperature and Discriminative Stimulus Effects of Nicotine and Menthol Aerosols in Male Rats: Role of α4β2 Nicotinic Acetylcholine Receptors.

    ACS chemical neuroscience·2026

    Protein Aggregates as Drivers of Receptor Clustering and Pathological Signaling: A Framework Linking Extracellular Amyloid-β to Tau Dysregulation.

    ACS chemical neuroscience·2026

    Mechanistic Characterization of NABi as a Selective Inhibitor of SOD1G93A Aggregation: Structural Basis and Therapeutic Implications for ALS.

    ACS chemical neuroscience·2026

    Development and Preclinical Evaluation of a Novel PET Probe for Phosphodiesterase 7B Imaging in Brain.

    ACS chemical neuroscience·2026

    Nitrogen Doping Reduces the Neurotoxic Effects of Graphene Quantum Dots by Suppressing Proinflammatory and Oxidative Stress Pathways.

    ACS chemical neuroscience·2026

    Development of Novel Pegylated Imidazobenzodiazepines Targeting α5 GABAA Receptors for Anxiety: A Comparative Prodrug and Metabolite Study.

    ACS chemical neuroscience·2026

    Clinical Efficacy of High-Frequency Deep Repetitive Transcranial Magnetic Stimulation in the Treatment of Depression and the Predictive Role of Baseline Triglyceride Levels: A Randomized Sham-Controlled Trial.

    Clinical EEG and neuroscience·2026

    Mechanistic Basis and Therapeutic Potential of a Novel TXNIP Inhibitor in Diabetes Treatment.

    Journal of medicinal chemistry·2026

    Discovery of BRD9 PROTAC/IMiD Bifunctional Molecules as Potent Therapeutics for Hematologic Malignancies.

    Journal of medicinal chemistry·2026

    First line asciminib in chronic myeloid leukemia: a quest for the "Holy Grail" of tolerability.

    Haematologica·2026

    Successful treatment of systemic juvenile xanthogranuloma with an ABL2::GAB2 fusion using dasatinib after failure of conventional chemotherapy and MEK inhibition.

    Haematologica·2026

    Repurposing MK0873 as a non-covalent hTERT-Targeting compound: a proof of concept study.

    Frontiers in aging·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us